LAVA Therapeutics BV (LVTX) Social Stream
LAVA THERAPEUTICS NV (LVTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LVTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | $24 | $22 | $23 | $1.53 | 1403.27% |
| 2021-11-16 | 3 | $23 | $20 | $21.666 | $1.53 | 1316.08% |
| 2022-03-24 | 3 | $23 | $20 | $21 | $1.53 | 1272.55% |
| 2022-04-20 | 2 | $23 | $19 | $20.666 | $1.53 | 1250.72% |
| 2022-05-17 | 3 | $23 | $19 | $20.666 | $1.53 | 1250.72% |
| 2022-05-18 | 3 | $25 | $23 | $24 | $1.53 | 1468.63% |
| 2022-06-01 | 3 | $25 | $18 | $22 | $1.53 | 1337.91% |
| 2022-08-02 | 3 | $25 | $18.001 | $22 | $1.53 | 1337.91% |
| 2022-09-16 | 4 | $25 | $6 | $18 | $1.53 | 1076.47% |
| 2022-09-27 | 5 | $28 | $6 | $18.75 | $1.53 | 1125.49% |
| 2022-10-25 | 5 | $28 | $6 | $16.8 | $1.53 | 998.04% |
| 2022-11-17 | 5 | $28 | $6 | $17.2 | $1.53 | 1024.18% |
| 2022-12-01 | 4 | $27 | $6 | $17 | $1.53 | 1011.11% |
| 2023-04-13 | 5 | $27 | $6 | $17 | $1.53 | 1011.11% |
| 2023-04-14 | 5 | $27 | $6 | $15.2 | $1.53 | 893.46% |
| 2023-06-12 | 5 | $27 | $6 | $13.6 | $1.53 | 788.89% |
| 2023-06-15 | 5 | $18 | $6 | $9.8 | $1.53 | 540.52% |
| 2023-08-22 | 4 | $10 | $6 | $7.75 | $1.53 | 406.54% |
| 2023-08-23 | 4 | $10 | $6 | $7 | $1.53 | 357.52% |
| 2023-11-17 | 4 | $11 | $6 | $7.666 | $1.53 | 401.05% |
The Trend in the Analyst Price Target
LVTX's average price target has moved down $16 over the prior 31 months.
LVTX reports an average of 459.81% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-13 | 5 | 27 | 6 | 17.00 | 1.60 | 962.5% |
| 2023-04-14 | 5 | 27 | 6 | 15.20 | 1.78 | 753.93% |
| 2023-05-25 | 5 | 27 | 6 | 13.60 | 1.89 | 619.58% |
| 2023-06-15 | 4 | 10 | 6 | 7.75 | 1.96 | 295.41% |
| 2023-08-22 | 4 | 10 | 6 | 7.75 | 1.83 | 323.5% |
LVTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 26 weeks, LVTX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LVTX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, LAVA THERAPEUTICS NV's upside potential (average analyst target price relative to current price) is greater than 2294.36% of them.
- To contextualize these metrics, consider that out of all US stocks, LAVA THERAPEUTICS NV's number of analysts covering the stock is greater than 324.56% of them.
- To contextualize these metrics, consider that out of all US stocks, LAVA THERAPEUTICS NV's variance in analysts' estimates is lower than -1354.66% of them.
- In terms of how LAVA THERAPEUTICS NV fares relative to Healthcare stocks, note that its average analyst price target is higher than 706.84% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LAVA THERAPEUTICS NV are EWTX, DSGN, and IMPL.
View All Top Stocks by Price Target
Is LVTX a Buy, Hold or Sell? See the POWR Ratings now!